BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29534999)

  • 1. Diverse signalling of the platelet P2Y
    Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
    Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of platelet P2Y
    Arkless KL; Pan D; Shankar-Hari M; Amison RT; Page CP; Rahman KM; Pitchford SC
    Br J Pharmacol; 2024 Feb; 181(4):564-579. PubMed ID: 36694432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoA signaling through platelet P2Y₁ receptor controls leukocyte recruitment in allergic mice.
    Amison RT; Momi S; Morris A; Manni G; Keir S; Gresele P; Page CP; Pitchford SC
    J Allergy Clin Immunol; 2015 Feb; 135(2):528-38. PubMed ID: 25445826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
    Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
    J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.
    Eckly A; Gendrault JL; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2001 Apr; 85(4):694-701. PubMed ID: 11341507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
    Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
    Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y
    Amison RT; Arnold S; O'Shaughnessy BG; Cleary SJ; Ofoedu J; Idzko M; Page CP; Pitchford SC
    Pulm Pharmacol Ther; 2017 Aug; 45():62-68. PubMed ID: 28487256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The naphthoquinone plumbagin suppresses ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathway.
    Zhang Q; Liao X; Wu F
    Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):573-578. PubMed ID: 28650323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring bias in platelet P2Y
    Pan D; Ladds G; Rahman KM; Pitchford SC
    Br J Pharmacol; 2024 Feb; 181(4):580-592. PubMed ID: 37442808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of P2Y
    Paul DS; Blatt TN; Schug WJ; Clark EG; Kawano T; Mackman N; Murcia S; Poe KO; Mwiza JMN; Harden TK; Bergmeier W; Nicholas RA
    J Thromb Haemost; 2023 Jul; 21(7):1891-1902. PubMed ID: 36958516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets.
    Koessler J; Hermann S; Weber K; Koessler A; Kuhn S; Boeck M; Kobsar A
    PLoS One; 2016; 11(1):e0147370. PubMed ID: 26808867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression.
    Massimi I; Alemanno L; Guarino ML; Guerriero R; Mancone M; Ceccacci A; Frati L; Angiolillo DJ; Pulcinelli FM
    Thromb Haemost; 2019 May; 119(5):726-734. PubMed ID: 30759486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
    Jones S; Evans RJ; Mahaut-Smith MP
    Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine restores platelet functions inhibited by ticagrelor: A mechanistic approach.
    Martin AC; Zlotnik D; Bonete GP; Baron E; Decouture B; Belleville-Rolland T; Le Bonniec B; Poirault-Chassac S; Alessi MC; Gaussem P; Godier A; Bachelot-Loza C
    Eur J Pharmacol; 2020 Jan; 866():172798. PubMed ID: 31738933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
    Kim KA; Song WG; Lee HM; Joo HJ; Park JY
    Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque.
    Dwivedi S; Pandey D; Khandoga AL; Brandl R; Siess W
    J Transl Med; 2010 Dec; 8():128. PubMed ID: 21134286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.